130 related articles for article (PubMed ID: 2478656)
21. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
[TBL] [Abstract][Full Text] [Related]
22. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
Fais F; Sellars B; Ghiotto F; Yan XJ; Dono M; Allen SL; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Schuster M; Vinciguerra VP; Rai K; Stevenson FK; Gregersen PK; Ferrarini M; Chiorazzi N
J Clin Invest; 1996 Oct; 98(7):1659-66. PubMed ID: 8833916
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
[TBL] [Abstract][Full Text] [Related]
24. B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
Neuber K; Berg-Drewniock B; Volkenandt M; Neumaier M; Zeller W; Gross G; Ring J
Dermatology; 1996; 192(2):110-5. PubMed ID: 8829490
[TBL] [Abstract][Full Text] [Related]
25. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
[TBL] [Abstract][Full Text] [Related]
26. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.
Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Ricci M; Bosi A; Romagnani S
Ric Clin Lab; 1989; 19(2):129-38. PubMed ID: 2528201
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.
Punnonen J; Aversa G; Cocks BG; McKenzie AN; Menon S; Zurawski G; de Waal Malefyt R; de Vries JE
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3730-4. PubMed ID: 8097323
[TBL] [Abstract][Full Text] [Related]
28. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R
Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823
[TBL] [Abstract][Full Text] [Related]
29. Anti-CD23 monoclonal antibodies: comparisons of epitope specificities and modulating capacities for IgE binding and production.
Wakai M; Pasley P; Sthoeger ZM; Posnett DN; Brooks R; Hashimoto S; Chiorazzi N
Hybridoma; 1993 Feb; 12(1):25-43. PubMed ID: 7681036
[TBL] [Abstract][Full Text] [Related]
30. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
31. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells.
Punnonen J; de Vries JE
J Immunol; 1994 Feb; 152(3):1094-102. PubMed ID: 7507958
[TBL] [Abstract][Full Text] [Related]
32. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching.
Jabara HH; Brodeur SR; Geha RS
J Clin Invest; 2001 Feb; 107(3):371-8. PubMed ID: 11160161
[TBL] [Abstract][Full Text] [Related]
34. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
35. Regulation of IgE synthesis by CD23/CD21 interaction.
Bonnefoy JY; Gauchat JF; Life P; Graber P; Aubry JP; Lecoanet-Henchoz S
Int Arch Allergy Immunol; 1995; 107(1-3):40-2. PubMed ID: 7542093
[TBL] [Abstract][Full Text] [Related]
36. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
37. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-15 + thioredoxin induce DNA synthesis in B-chronic lymphocytic leukemia cells but not in normal B cells.
Söderberg O; Christiansen I; Nilsson G; Carlsson M; Nilsson K
Leukemia; 1997 Aug; 11(8):1298-304. PubMed ID: 9264384
[TBL] [Abstract][Full Text] [Related]
39. Functional studies of chronic lymphocytic leukemia B cells expressing β
Uzonyi B; Mácsik-Valent B; Lukácsi S; Kiss R; Török K; Kremlitzka M; Bajtay Z; Demeter J; Bödör C; Erdei A
Immunol Lett; 2017 Sep; 189():73-81. PubMed ID: 28577901
[TBL] [Abstract][Full Text] [Related]
40. A scoring system for the classification of CD5-B CLL versus CD5+ B CLL and B PLL.
Salomon-Nguyen F; Valensi F; Merle-Beral H; Flandrin G
Leuk Lymphoma; 1995 Feb; 16(5-6):445-50. PubMed ID: 7540458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
